Pharmaceuticals, Biotechnology and Life Sciences
BERKELEY HEIGHTS, N.J., Dec. 05, 2024 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”),…
Article 223-16 of general regulation of French Autorité des Marchés Financiers Listing market: Euronext Paris (Market segment C – ISIN Code:…
Data Support Start of First Pivotal Trial for an Off-the-Shelf, Allogeneic CD7-Targeted CAR-T Cell Therapy in Pediatric and Adult PatientsST.…
WARREN, N.J., Dec. 05, 2024 (GLOBE NEWSWIRE) — Dr. Ryan Saadi, CEO of Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings…
Measure your biological age with cutting-edge epigenetic testing, 85% more affordable than competitors, bringing advanced longevity science within reach for…
Company will leverage recent financing and joint development agreement with electric aviation manufacturing partner to develop safer and more efficient…
Carlsbad, CA, Dec. 05, 2024 (GLOBE NEWSWIRE) — Qualigen Therapeutics (NASDAQ: QLGN) (the “Company” or “Qualigen”) today announced that the…
Pooled data analysis of efficacy and safety from Phase 2b and Phase 3 data sets in patients with early-stage Parkinson’s…
Company Refocuses on Sycamore BioPharma, Navigates Challenges, and Prepares for Rebranding to Royal Enterprises, IncORLANDO, Fla., Dec. 05, 2024 (GLOBE…
CAMBRIDGE, Mass., Dec. 05, 2024 (GLOBE NEWSWIRE) — Alkeus Pharmaceuticals, Inc. today announced that results from its clinical studies of…